1. Home
  2. CMRX vs DOGZ Comparison

CMRX vs DOGZ Comparison

Compare CMRX & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMRX
  • DOGZ
  • Stock Information
  • Founded
  • CMRX 2000
  • DOGZ 2003
  • Country
  • CMRX United States
  • DOGZ China
  • Employees
  • CMRX 81
  • DOGZ N/A
  • Industry
  • CMRX Biotechnology: Pharmaceutical Preparations
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • CMRX Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • CMRX Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • CMRX 797.3M
  • DOGZ 342.7M
  • IPO Year
  • CMRX 2013
  • DOGZ 2017
  • Fundamental
  • Price
  • CMRX $8.50
  • DOGZ $27.83
  • Analyst Decision
  • CMRX Hold
  • DOGZ
  • Analyst Count
  • CMRX 4
  • DOGZ 0
  • Target Price
  • CMRX $8.51
  • DOGZ N/A
  • AVG Volume (30 Days)
  • CMRX 8.4M
  • DOGZ 81.0K
  • Earning Date
  • CMRX 03-21-2025
  • DOGZ 05-16-2025
  • Dividend Yield
  • CMRX N/A
  • DOGZ N/A
  • EPS Growth
  • CMRX N/A
  • DOGZ N/A
  • EPS
  • CMRX N/A
  • DOGZ N/A
  • Revenue
  • CMRX $212,000.00
  • DOGZ $20,258,926.00
  • Revenue This Year
  • CMRX $2,685.38
  • DOGZ N/A
  • Revenue Next Year
  • CMRX $1,050.23
  • DOGZ N/A
  • P/E Ratio
  • CMRX N/A
  • DOGZ N/A
  • Revenue Growth
  • CMRX N/A
  • DOGZ N/A
  • 52 Week Low
  • CMRX $0.75
  • DOGZ $5.40
  • 52 Week High
  • CMRX $8.53
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • CMRX 83.05
  • DOGZ 46.45
  • Support Level
  • CMRX $8.41
  • DOGZ $26.00
  • Resistance Level
  • CMRX $8.52
  • DOGZ $29.18
  • Average True Range (ATR)
  • CMRX 0.02
  • DOGZ 2.72
  • MACD
  • CMRX -0.15
  • DOGZ 0.01
  • Stochastic Oscillator
  • CMRX 62.50
  • DOGZ 21.45

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: